Federal cannabis policy moved deeper into implementation as the DEA opened specialized registration channels for medical marijuana businesses and opponents escalated a challenge to a Medicare hemp initiative. In Hollywood, Paramount completed its Warner Bros. Discovery acquisition, formally creating Skydance.
Tag: Paramount
Cannabis M&A Escalates as Skydance Sets Its Power Structure
Curaleaf raised its hostile offer for Aurora Cannabis, while a cannabinoid drug developer reported progress toward an FDA veterinary pathway. In entertainment, Paramount named the leadership structure expected to oversee its combined business with Warner Bros. Discovery.
Cannabis Capital Risks Rise as Paramount Deal Hits a Judicial Pause
Two cannabis lawsuits spotlight financing and data-security risks for licensed retailers, while a federal judge delays approval of the settlement intended to clear Paramount’s Warner Bros. Discovery acquisition.
Cannabis Rulebooks Expand as Hollywood Merger Talks Fray
Virginia and Nevada are advancing consequential cannabis regulations covering market entry, retail operations and laboratory testing. In Hollywood, growing opposition and dissent among state attorneys general are complicating settlement talks over Paramount’s proposed Warner Bros. Discovery takeover.
Cannabis Policy Moves as Hollywood Megamerger Talks Accelerate
A bipartisan federal bill targets cannabis-related barriers to government employment, while Maine regulators warn patients about contaminated concentrate. In Hollywood, settlement negotiations could determine the fate of Paramount’s proposed Warner Bros. Discovery takeover.
Cannabis Contract Shock and Hollywood’s Merger Standoff
A federal appeals court erased a $31.8 million cannabis verdict, Ohio activated detailed product rules, and Paramount’s contested Warner Bros. acquisition moved toward court-ordered settlement talks.
